| 68 Ga-DOTATATE and 18 F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity CA Chang, DA Pattison, RW Tothill, G Kong, TJ Akhurst, RJ Hicks, ... Cancer Imaging 16 (1), 1-12, 2016 | 86 | 2016 |
| Efficacy of peptide receptor radionuclide therapy for functional metastatic paraganglioma and pheochromocytoma G Kong, S Grozinsky-Glasberg, MS Hofman, J Callahan, A Meirovitz, ... The Journal of Clinical Endocrinology & Metabolism 102 (9), 3278-3287, 2017 | 66 | 2017 |
| Cardiovascular risk and bone loss in men undergoing androgen deprivation therapy for non‐metastatic prostate cancer: implementation of standardized management guidelines AS Cheung, D Pattison, I Bretherton, R Hoermann, D Lim Joon, E Ho, ... Andrology 1 (4), 583-589, 2013 | 46 | 2013 |
| Long-term follow-up and outcomes of retreatment in an expanded 50-patient single-center phase II prospective trial of 177Lu-PSMA-617 theranostics in metastatic castration … J Violet, S Sandhu, A Iravani, J Ferdinandus, SP Thang, G Kong, ... Journal of Nuclear Medicine 61 (6), 857-865, 2020 | 45 | 2020 |
| High clinical and morphologic response using 90 Y-DOTA-octreotate sequenced with 177 Lu-DOTA-octreotate induction peptide receptor chemoradionuclide therapy (PRCRT) for bulky … G Kong, J Callahan, MS Hofman, DA Pattison, T Akhurst, M Michael, P Eu, ... European journal of nuclear medicine and molecular imaging 44 (3), 476-489, 2017 | 30 | 2017 |
| TheraP: A randomised phase II trial of 177Lu-PSMA-617 (LuPSMA) theranostic versus cabazitaxel in metastatic castration resistant prostate cancer (mCRPC … MS Hofman, L Emmett, SK Sandhu, A Iravani, AM Joshua, JC Goh, ... Journal of Clinical Oncology 38 (15_suppl), 5500-5500, 2020 | 29 | 2020 |
| Quantitative assessment of thyroid-to-background ratio improves the interobserver reliability of technetium-99m sestamibi thyroid scintigraphy for investigation of amiodarone … DA Pattison, J Westcott, M Lichtenstein, HB Toh, D Gunawardana, ... Nuclear medicine communications 36 (4), 356-362, 2015 | 23 | 2015 |
| Intermittent severe, symptomatic hyponatraemia due to the nephrogenic syndrome of inappropriate antidiuresis S Soule, C Florkowski, H Potter, D Pattison, M Swan, P Hunt, P George Annals of clinical biochemistry 45 (5), 520-523, 2008 | 23 | 2008 |
| 64Cu-SARTATE PET imaging of patients with neuroendocrine tumors demonstrates high tumor uptake and retention, potentially allowing prospective dosimetry for peptide receptor … RJ Hicks, P Jackson, G Kong, RE Ware, MS Hofman, DA Pattison, ... Journal of Nuclear Medicine 60 (6), 777-785, 2019 | 22 | 2019 |
| Strongyloidiasis in personnel of the Regional Assistance Mission to Solomon Islands (RAMSI) DA Pattison, R Speare Medical journal of Australia 189 (4), 203-206, 2008 | 22 | 2008 |
| Molecular imaging in the investigation of hypoglycaemic syndromes and their management DA Pattison, RJ Hicks Endocrine-related cancer 24 (6), R203-R221, 2017 | 21 | 2017 |
| Role of fluorodeoxyglucose PET/computed tomography in targeted radionuclide therapy for endocrine malignancies DA Pattison, MS Hofman PET clinics 10 (4), 461-476, 2015 | 17 | 2015 |
| 18F-FDG–avid thyroid incidentalomas: the importance of contextual interpretation DA Pattison, M Bozin, A Gorelik, MS Hofman, RJ Hicks, A Skandarajah Journal of Nuclear Medicine 59 (5), 749-755, 2018 | 14 | 2018 |
| Amiodarone-induced destructive thyroiditis associated with coronary artery vasospasm and recurrent ventricular fibrillation MJ Brooks, DA Pattison, EP Teo, S Price, R Gurvitch European thyroid journal 2 (1), 65-67, 2013 | 14 | 2013 |
| Enhanced white adipose tissue metabolism in iatrogenic Cushing's syndrome with FDG PET/CT DA Pattison, MS Hofman, E Lau, R Ware, RJ Hicks The Journal of Clinical Endocrinology & Metabolism 99 (9), 3041-3042, 2014 | 11 | 2014 |
| Diagnostic challenges in a patient with an occult insulinoma: 68 Ga‐DOTA‐exendin‐4 PET/CT and 68Ga‐DOTATATE PET/CT E Bongetti, MH Lee, DA Pattison, RJ Hicks, R Norris, N Sachithanandan, ... Clinical case reports 6 (4), 719, 2018 | 10 | 2018 |
| A new theranostic paradigm for advanced thyroid cancer DA Pattison, B Solomon, RJ Hicks Journal of Nuclear Medicine 57 (10), 1493-1494, 2016 | 9 | 2016 |
| 15th international thyroid congress program and meeting abstracts RN Miguel, J Sanders, J Furmaniak, BR Smith, C Li, F Menconi, R Osman, ... Thyroid 25 (S1), P-1-A-337, 2015 | 8 | 2015 |
| Mitogen-activated protein kinase pathway inhibition for Redifferentiation of radioiodine refractory differentiated thyroid Cancer: an evolving protocol A Iravani, B Solomon, DA Pattison, P Jackson, A Ravi Kumar, G Kong, ... Thyroid 29 (11), 1634-1645, 2019 | 6 | 2019 |
| First-in-human trial of 64Cu-SARTATE PET imaging of patients with neuroendocrine tumours demonstrates high tumor uptake and retention, potentially allowing prospective … RJ Hicks, P Jackson, G Kong, RE Ware, MS Hofman, DA Pattison, ... Journal of Nuclear Medicine, jnumed. 118.217745, 2018 | 5 | 2018 |
